Standardized for diagnosing and monitoring diabetes, the fully-automated whole-blood glycated hemoglobin (HbA1c) assay gives your laboratory elevated confidence in results, increased efficiency, and minimized tech hands-on time.
Diabetes has been called the 21st century’s major public health concern and represents a serious global epidemic.
The HbA1c assay is designed to have diagnostics and monitoring claims for diabetes mellitus on the Alinity c, ARCHITECT c4000 and ARCHITECT c8000 systems. The assay is a fully automated whole blood application with no manual pretreatment steps and does not have significant interference from common hemoglobin variants.
HbA1c is a high-quality diagnostic tool in diabetes diagnosis and management providing an improved patient management process, enhanced confidence in patient results and improved laboratory workflow efficiencies.
Our extensive assay menu helps physicians make timely, informed decisions throughout the continuum of care.
Learn about the innovative total laboratory automation solution with proven technology and flexibility to meet your goals.
Discover how Alinity uses powerful technology to help redefine and improve operational productivity and confidence in your laboratory.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott. The website that you have requested also may not be optimised for your screen size.
Please be aware that the website you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
